309 related articles for article (PubMed ID: 16900734)
1. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
Vussuki E; Ziv M; Rosenman D; David M
Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
[TBL] [Abstract][Full Text] [Related]
2. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
Parsad D; Kanwar AJ; Kumar B
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
[TBL] [Abstract][Full Text] [Related]
3. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
Westerhof W; Nieuweboer-Krobotova L
Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
[TBL] [Abstract][Full Text] [Related]
4. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
5. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
6. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
[TBL] [Abstract][Full Text] [Related]
7. Long-term results in the treatment of vitiligo with oral khellin plus UVA.
Hofer A; Kerl H; Wolf P
Eur J Dermatol; 2001; 11(3):225-9. PubMed ID: 11358729
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients.
Radmanesh M; Saedi K
J Dermatolog Treat; 2006; 17(3):151-3. PubMed ID: 16854754
[TBL] [Abstract][Full Text] [Related]
9. Chronic cutaneous effects of long-term psoralen and ultraviolet radiation therapy in patients with vitiligo.
Harrist TJ; Pathak MA; Mosher DB; Fitzpatrick TB
Natl Cancer Inst Monogr; 1984 Dec; 66():191-6. PubMed ID: 6531028
[TBL] [Abstract][Full Text] [Related]
10. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo.
Buckley DA; Rogers S
Clin Exp Dermatol; 1996 Jan; 21(1):43-5. PubMed ID: 8689768
[TBL] [Abstract][Full Text] [Related]
11. Calcipotriol and PUVA as treatment for vitiligo.
Cherif F; Azaiz MI; Ben Hamida A; Ben O; Dhari A
Dermatol Online J; 2003 Dec; 9(5):4. PubMed ID: 14996377
[TBL] [Abstract][Full Text] [Related]
12. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study.
Yalçin B; Sahin S; Bükülmez G; Karaduman A; Atakan N; Akan T; Kölemen F
J Am Acad Dermatol; 2001 Apr; 44(4):634-7. PubMed ID: 11260538
[TBL] [Abstract][Full Text] [Related]
13. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
[TBL] [Abstract][Full Text] [Related]
14. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
15. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
[TBL] [Abstract][Full Text] [Related]
16. Treatment of vitiligo with broadband ultraviolet B and vitamins.
Don P; Iuga A; Dacko A; Hardick K
Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
[TBL] [Abstract][Full Text] [Related]
17. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
Stern RS;
J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
[TBL] [Abstract][Full Text] [Related]
18. Treatment of vitiligo with oral methoxsalen and UVA.
Lassus A; Halme K; Eskelinen A; Ranki A; Puska P; Salo O
Photodermatol; 1984 Aug; 1(4):170-3. PubMed ID: 6531291
[TBL] [Abstract][Full Text] [Related]
19. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
Abdel-Naser MB; Hann SK; Bystryn JC
Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
[TBL] [Abstract][Full Text] [Related]
20. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
Sapam R; Agrawal S; Dhali TK
Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]